Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03418519
Other study ID # 2017-11-120
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 9, 2018
Est. completion date December 30, 2019

Study information

Verified date February 2019
Source Samsung Medical Center
Contact YoungSub Hwang, researcher
Phone +821027182034
Email asiaargento@naver.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates CIMT(Constraint Induced Movement Therapy) in the treatment of physical activity performance and motor function of the weaker extremity in young children with cerebral palsy. Half of participants will receive CIMT while the other half will receive no treatment.


Description:

Constraint-induced movement therapy (CIMT) is a short-term, intensive treatment to promote functional arm and hand skills in people with hemiparesis. It usually involves constraint of the non-involved extremity and intensive movement practice of the weaker extremity.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 30, 2019
Est. primary completion date April 8, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Months to 36 Months
Eligibility Inclusion Criteria:

- diagnosed with spastic hemiplegic cerebral palsy

- age between 18 months and 36 months

- Mini-MACS level 1-4

Exclusion Criteria:

- botox injection in upper extremity within 6 months

- poor cooperation with cognitive impairment

- any musculoskeletal disease

- visual or hearing impairment

- uncontrollable epilepsy

- skin damage that makes impossible for participant to wear a splint

- Mini-MACS level 5

Study Design


Related Conditions & MeSH terms

  • Cerebral Palsy
  • Hemiplegic Cerebral Palsy With Spasticity (Diagnosis)

Intervention

Other:
Constraint Induced Movement Therapy
Constraint-induced movement therapy (CIMT) is a high-dosage, efficacious, rehabilitation approach used for children with hemiplegic cerebral palsy

Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accelerometers(physical activity performance) For the upper limb use assessment, participants wear two accelerometers (one on each wrist). To quantify the affected upper limb movement relative to the unaffected upper limb before and after the CIMT program, two other variables are computed: use ratio and magnitude ratio. The use ratio is the ratio of the active duration for the affected arm to that for the unaffected arm. The magnitude ratio quantifies the contribution of the affected upper limb to activity. 3 days
Primary Pediatric Motor Activity Log(PMAL) The Pediatric Motor Activity Log (PMAL) is a parent-report measure of the use, by children with hemiplegic cerebral palsy, of their affected upper limb in everyday activities. Each item is scored 0-5(0= Never used affected arm , 5= Used affected arm on almost every occasion) 30 minutes
Secondary Pediatric Evaluation of Disability Inventory(PEDI) The PEDI is a parental-report, or structured-interview, instrument used by pediatric physical therapists and other rehabilitation professionals to assess functional abilities of young children children 30 minutes
Secondary Peabody Developmental Motor Scales-2(PDMS-2) The PDMS-2 consists of six subtests: Reflexes (for children from birth through 11 months), Stationary (ability to sustain control of body within its center of gravity), Locomotion (ability to move from one place to another), Object Manipulation (ability to manipulate balls for children 12 months and older), Grasping (ability to use hands), and Visual-Motor Integration (ability to use visual perpetual skills to perform complex eye-hand coordination tasks). 30 minutes
Secondary Gross motor function measure - 66(GMFM-66) The 88 items of the GMFM are measured by observation of the child and scored on a 4-point ordinal scale (0=does not initiate, 1=initiates <10% of activity, 2=partially completes 10% to <100% of activity, 3=completes activity). The items are weighted equally and grouped into 5 dimensions: (1) lying and rolling (17 items), (2) sitting (20 items), (3) crawling and kneeling (14 items), (4) standing (13 items), and (5) walking, running, jumping (24 items). 30 minutes